OBJECTIVE: The insertion of conventional intrauterine devices (IUDs) during the 1st 10 days after delivery is associated with a high rate of expulsions. DESIGN: The GYNE-T 380 (Ortho Pharmaceutical [Canada] Ltd., Toronto, Ontario, Canada) IUD was modified by the addition of a loose loop of knotted biodegradable no. 2 catgut to the top of the IUD (GYNE-T 380 postpartum IUD). After delivery, a special inserter was used to imbed the knotted portion of the loop into the myometrium of the uterine fundus. PATIENTS, PARTICIPANTS: This modified IUD was evaluated in a phase II trial involving 190 women at four clinical sites. MAIN OUTCOME MEASURES: There were no pregnancies during the 1st year of the study. The continuation rate was 74 per 100 women and a life table expulsion rate of 9.6 and 13.3 per 100 women was observed at 6 and 12 months, respectively. RESULTS: Complications associated with the insertion and the use of this IUD were minimal. Large scale trials evaluating this IUD are in progress.
OBJECTIVE: The insertion of conventional intrauterine devices (IUDs) during the 1st 10 days after delivery is associated with a high rate of expulsions. DESIGN: The GYNE-T 380 (Ortho Pharmaceutical [Canada] Ltd., Toronto, Ontario, Canada) IUD was modified by the addition of a loose loop of knotted biodegradable no. 2 catgut to the top of the IUD (GYNE-T 380 postpartum IUD). After delivery, a special inserter was used to imbed the knotted portion of the loop into the myometrium of the uterine fundus. PATIENTS, PARTICIPANTS: This modified IUD was evaluated in a phase II trial involving 190 women at four clinical sites. MAIN OUTCOME MEASURES: There were no pregnancies during the 1st year of the study. The continuation rate was 74 per 100 women and a life table expulsion rate of 9.6 and 13.3 per 100 women was observed at 6 and 12 months, respectively. RESULTS: Complications associated with the insertion and the use of this IUD were minimal. Large scale trials evaluating this IUD are in progress.
Entities:
Keywords:
Americas; Belgium; Clinical Research; Contraception; Contraception Continuation; Contraception Termination; Contraceptive Effectiveness; Contraceptive Methods; Contraceptive Usage; Demographic Analysis; Denmark; Developed Countries; Developing Countries; Europe; Evaluation; Family Planning; Follow-up Studies; Insertion; Iud; Iud, Copper Releasing; Latin America; Life Table Method; Method Acceptability; Netherlands; Northern Europe; Postpartum Women; Puerperium; Reproduction; Research Methodology; Risk Assessment; Scandinavia; South America; Studies; Treatment; Venezuela; Western Europe
Authors: David Canning; Iqbal H Shah; Erin Pearson; Elina Pradhan; Mahesh Karra; Leigh Senderowicz; Till Bärnighausen; Donna Spiegelman; Ana Langer Journal: BMC Pregnancy Childbirth Date: 2016-11-21 Impact factor: 3.007